XML 40 R26.htm IDEA: XBRL DOCUMENT v3.20.2
RESTATEMENT OF CONSOLIDATED FINANCIAL STATEMENTS (Tables)
12 Months Ended
Dec. 31, 2019
RESTATEMENT OF CONSOLIDATED FINANCIAL STATEMENTS  
Schedule of effects of the restatement on the consolidated financial statements

The effects of the restatement on the consolidated balance sheets are summarized in the following table:

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2019

 

    

As Originally

    

 

 

    

 

 

 

 

Reported

 

Adjustments

 

As Restated

ASSETS

 

 

  

 

 

  

 

 

  

Current Assets

 

 

  

 

 

  

 

 

  

Cash and Cash Equivalents

 

$

122,390

 

$

 —

 

$

122,390

Accounts receivable, net

 

 

85,204

 

 

 —

 

 

85,204

Note receivable, net – current portion

 

 

375,000

 

 

 —

 

 

375,000

Prepaid expenses and other current assets

 

 

546,970

 

 

 —

 

 

546,970

Assets held for sale

 

 

375,218

 

 

 —

 

 

375,218

Assets of discontinued operations

 

 

47,453

 

 

 —

 

 

47,453

Total Current Assets

 

$

1,552,235

 

 

 —

 

$

1,552,235

 

 

 

 

 

 

 

 

 

 

Note receivable, net

 

 

93,333

 

 

 —

 

 

93,333

Property and equipment, net

 

 

1,507,327

 

 

 —

 

 

1,507,327

Investment

 

 

250,000

 

 

 —

 

 

250,000

Assets held for sale

 

 

15,584

 

 

 —

 

 

15,584

Assets of discontinued operations

 

 

83,525

 

 

 —

 

 

83,525

Total Assets

 

$

3,502,004

 

$

 —

 

$

3,502,004

 

 

 

 

 

 

 

 

 

 

LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

  

 

 

  

 

 

  

Current Liabilities

 

 

  

 

 

  

 

 

  

Accounts payable and accrued expenses

 

$

1,221,194

 

$

 —

 

$

1,221,194

Interest payable

 

 

93,375

 

 

 —

 

 

93,375

Customer deposits

 

 

562,803

 

 

 —

 

 

562,803

Accrued stock payable

 

 

80,657

 

 

 —

 

 

80,657

Notes payable (net of discount)

 

 

2,230,684

 

 

 —

 

 

2,230,684

Related party note payable (net of discount)

 

 

99,667

 

 

 —

 

 

99,667

Warrant derivative liability

 

 

1,599,436

 

 

3,201,157

 

 

4,620,593

Liabilities held for sale

 

 

149,249

 

 

 —

 

 

149,249

Liabilities of discontinued operations

 

 

207,993

 

 

 —

 

 

207,993

Total current liabilities

 

$

6,245,058

 

$

3,201,157

 

$

9,266,216

Stockholders’ Equity (Deficit)

 

 

  

 

 

  

 

 

  

Common Stock

 

 

39,498

 

 

 —

 

 

39,498

Additional paid-in capital

 

 

61,468,034

 

 

 —

 

 

61,468,034

Accumulated deficit

 

 

(64,250,586)

 

 

(3,201,157)

 

 

(67,271,744)

Total Stockholders’ Equity (Deficit)

 

$

(2,743,054)

 

$

(3,201,157)

 

$

(5,764,212)

Total Liabilities & Stockholders’ Equity (Deficit)

 

 

 

 

 

 

 

 

 

 

 

$

3,502,004

 

$

 —

 

$

3,502,004

 


The effects of the restatement on the consolidated statements of operations and comprehensive income/loss are summarized in the following table:

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2019

 

 

As Originally

 

 

 

 

 

 

 

    

 Reported

    

Adjustments

    

As Restated

Revenues

 

 

  

 

 

  

 

 

  

Services

 

$

1,787,863

 

$

 —

 

$

1,787,863

Rent and interest

 

 

95,437

 

 

 —

 

 

95,437

Product sale

 

 

1,783,046

 

 

 —

 

 

1,783,046

Total revenues

 

 

3,666,346

 

 

 —

 

 

3,666,346

Costs and Expenses

 

 

  

 

 

  

 

 

  

Cost of service revenues

 

 

858,714

 

 

 —

 

 

858,714

Cost of goods sold

 

 

1,608,386

 

 

 —

 

 

1,608,386

Selling, general, and administrative

 

 

4,379,800

 

 

 —

 

 

4,379,800

Share-based expense

 

 

3,966,621

 

 

 —

 

 

3,966,621

Professional fees

 

 

1,598,818

 

 

 —

 

 

1,598,818

Depreciation and amortization

 

 

115,696

 

 

 —

 

 

115,696

Total costs and expenses

 

 

12,528,035

 

 

 —

 

 

12,528,035

 

 

 

 

 

 

 

 

 

 

Operating Loss

 

 

(8,861,689)

 

 

 —

 

 

(8,861,689)

Other (Income) Expense

 

 

  

 

 

  

 

 

  

Amortization of debt discount and equity issuance costs

 

 

 

 

 

 

 

 

 

 

 

 

2,019,726

 

 

 —

 

 

2,019,726

Loss on extinguishment of debt

 

 

377,300

 

 

 —

 

 

377,300

Interest expense, net

 

 

345,371

 

 

 —

 

 

345,371

(Gain) loss on warrant derivative liability

 

 

(816,916)

 

 

3,201,157

 

 

2,204,172

Total other expense, net

 

 

1,925,411

 

 

3,201,157

 

 

4,946,569

 

 

 

 

 

 

 

 

 

 

Net Loss from Continuing Operations

 

$

(10,787,100)

 

$

(3,201,157)

 

$

(13,808,258)

Loss from discontinued operations

 

 

(1,675,539)

 

 

 —

 

 

(1,675,539)

Net Loss

 

$

(12,462,639)

 

$

(3,201,157)

 

$

(15,483,797)

Deemed dividend

 

 

(2,341,000)

 

 

 —

 

 

(2,341,000)

Net Loss Attributable to Common Stockholders

 

$

(14,803,639)

 

$

(3,201,157)

 

$

(17,824,797)

 

 

 

 

 

 

 

 

 

 

Per Share Data – Basic and diluted

 

 

  

 

 

  

 

 

  

Net loss from continuing operations

 

$

(0.28)

 

$

(0.08)

 

$

(0.36)

Net loss from discontinued operations

 

$

(0.04)

 

$

 —

 

$

(0.04)

Net loss attributable to common stockholders per share

 

$

(0.39)

 

$

(0.08)

 

$

(0.47)

Weighted average number of common shares outstanding

 

 

38,106,781

 

 

 —

 

 

38,106,781

 

The effects of the restatement on the consolidated statement of cash flows are summarized in the following table:

 


 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2019

 

    

As Originally 

    

 

 

    

 

 

 

 

Reported

 

Adjustments

 

As Restated

Operating Activities

 

 

 

 

 

 

 

 

 

Net loss

 

$

(12,462,639)

 

$

(3,201,157)

 

$

(15,483,797)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

  

 

 

  

 

 

  

Amortization of debt discount and equity issuance costs

 

 

2,019,726

 

 

 —

 

 

2,019,726

Loss on extinguishment of debt

 

 

377,300

 

 

 —

 

 

377,300

Depreciation and amortization expense

 

 

196,247

 

 

 —

 

 

196,247

Amortization of loan origination fees

 

 

(13,333)

 

 

 —

 

 

(13,333)

Bad debt expense

 

 

174,249

 

 

 —

 

 

174,249

Impairment of assets

 

 

147,035

 

 

 —

 

 

147,035

Loss on disposal of property and equipment

 

 

104,803

 

 

 —

 

 

104,803

(Gain) loss on warrant derivative liability

 

 

(816,986)

 

 

3,201,157

 

 

2,204,172

Share-based payments

 

 

3,966,621

 

 

 —

 

 

3,966,621

Changes in operating assets and liabilities:

 

 

  

 

 

  

 

 

  

Accounts receivable

 

 

(101,766)

 

 

 —

 

 

(101,766)

Prepaid expenses and other assets

 

 

(138,254)

 

 

 —

 

 

(138,254)

Inventory

 

 

(23,772)

 

 

 —

 

 

(23,772)

Accounts payable and accrued liabilities

 

 

1,242,108

 

 

 —

 

 

1,242,108

Net cash used in operating activities:

 

 

(5,328,661)

 

 

 —

 

 

(5,328,661)

 

 

 

 

 

 

 

 

 

 

INVESTING ACTIVITIES

 

 

  

 

 

  

 

 

  

Purchase of property and equipment

 

 

(318,639)

 

 

 —

 

 

(318,639)

Lending on notes receivable

 

 

(705,000)

 

 

 —

 

 

(705,000)

Proceeds on notes receivable

 

 

270,000

 

 

 —

 

 

270,000

Net cash used in investing activities

 

 

(753,639)

 

 

 —

 

 

(753,639)

 

 

 

 

 

 

 

 

 

 

FINANCING ACTIVITIES

 

 

  

 

 

  

 

 

  

Proceeds from sale of common stock and warrants

 

 

2,604,355

 

 

 —

 

 

2,604,355

Proceeds from exercise of stock options

 

 

188,770

 

 

 —

 

 

188,770

Proceeds from notes payable

 

 

1,455,000

 

 

 —

 

 

1,455,000

Payments on notes payable

 

 

(5,898,000)

 

 

 —

 

 

(5,898,000)

Payments on Infinity Note - related party

 

 

 —

 

 

 —

 

 

 —

Net cash provided by (used in) financing activities

 

 

(1,649,875)

 

 

 —

 

 

(1,649,875)

 

 

 

 

 

 

 

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

 

 

(7,732,175)

 

 

 —

 

 

(7,732,175)

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

 

 

7,957,169

 

 

 —

 

 

7,957,169

CASH AND CASH EQUIVALENTS, END OF PERIOD

 

$

224,994

 

$

 —

 

$

224,994

SUPPLEMENTAL SCHEDULE OF CASH FLOW INFORMATION

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid for interest

 

$

305,195

 

$

 —

 

$

305,195

 

 

 

 

 

 

 

 

 

 

NON-CASH INVESTING & FINANCING ACTIVITIES

 

 

  

 

 

  

 

 

  

Deemed dividend from warrant repricing

 

$

2,603,000

 

$

 —

 

$

2,603,000

Operating lease right-of-use asset/Operating lease liability

 

 

154,200

 

 

 —

 

 

154,200

12% Warrants recorded as a debt discount and loss on extinguishment of debt

 

 

392,000

 

 

 —

 

 

392,000

SBI Warrants recorded as a debt discount and loss on extinguishment of debt

 

 

28,800

 

 

 —

 

 

28,800

15% Warrants recorded as a debt discount and additional paid-in capital

 

 

158,100

 

 

 —

 

 

158,100